Inflammatix, Inc., a pioneering molecular diagnostics company, announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company's...
Bridge to Life, Ltd. ("Bridge to Life" or the "Company"), a leading global supplier of organ preservation solutions and organ perfusion technologies, announced breakthrough...
Pathogenomix Inc., a Next Generation Sequencing, pathogen diagnostic company, announced that the US Food and Drug Administration (FDA) has granted it a Breakthrough Device...
